Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 119 | 80 | 46 | 152 | 165 |
| Cost of Goods | 276 | 142 | 61 | 257 | 304 |
| Gross Profit | -157 | -62 | -15 | -105 | -139 |
| Operating Expenses | 1,785 | 4,478 | 3,544 | 3,833 | 4,501 |
| Operating Income | -1,666 | -4,398 | -3,498 | -3,681 | -4,336 |
| Interest Expense | 0 | -70 | -102 | 0 | 0 |
| Other Income | 41 | 0 | -33 | 34 | 11 |
| Pre-tax Income | -1,625 | -4,328 | -3,429 | -3,647 | -4,325 |
| Net Income Continuous | -1,625 | -4,328 | -3,429 | -3,647 | -4,325 |
| Net Income Discontinuous | N/A | -152 | -830 | 184 | -1,480 |
| Net Income | $-1,625 | $-4,448 | $-4,259 | $-3,463 | $-5,805 |
| EPS Basic Total Ops | -0.26 | -0.71 | -0.71 | -0.59 | -0.99 |
| EPS Basic Continuous Ops | -0.26 | -0.69 | -0.57 | -0.62 | -0.74 |
| EPS Basic Discontinuous Ops | N/A | -0.02 | -0.14 | 0.03 | -0.25 |
| EPS Diluted Total Ops | -0.26 | -0.71 | -0.71 | -0.59 | -0.99 |
| EPS Diluted Continuous Ops | -0.26 | -0.69 | -0.57 | -0.62 | -0.74 |
| EPS Diluted Discontinuous Ops | N/A | -0.02 | -0.14 | 0.03 | -0.25 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | -0.62 | -0.75 |
| EBITDA(a) | $-1,579 | $-4,205 | $-3,300 | $-3,483 | $-4,129 |